The most common malignant germ cell tumor of early childhood is the endodermal sinus tumor (CEST), also known as yolk sac tumor. Previous cytogenetic studies of CEST have demonstrated recurrent deletion of distal regions of chromosomes 1p and 6q. Studies utilizing comparative genomic hybridization have likewise demonstrated loss of distal 6q, however these studies show discrepant data concerning chromosome 1 abnormalities. This study analyses 18 CESTs for loss of heterozygosity (LOH) of distal chromosome 6q utilizing 17 microsatellite markers and 13 tumors were analysed for LOH of distal 1p using two microsatellite markers. LOH of 6q was found in 13/18 tumors (72 %). This data con®rms that loss of genetic material on 6q is one of the most common abnormalities in CESTs and narrows the region of loss, enabling candidate tumor suppressor genes to be identi®ed and analysed. In addition, LOH of 1p36 was identi®ed in ®ve of 11 informative tumors, clarifying prior con¯icting data and con®rming that 1p deletion is a common event in CESTs. Oncogene (2001) 20, 8042 ± 8044.
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Keywords: germ cell tumor; endodermal sinus tumor; 6q; 1p36; IGF2R Germ cell tumors are a diverse group of tumors that share a presumed common cell of origin, the primordial germ cell. Malignant germ cell tumors can be subdivided into those arising before and those arising after puberty. Cytogenetic studies have shown that the most common chromosomal abnormalities in post-pubertal malignant germ cell tumors are the isochromosome 12p, loss of 13 and gain of chromosome 21 (Castedo et al., 1989; Riopel et al., 1998) . Malignant germ cell tumors prior to puberty demonstrate recurrent deletion of distal chromosome 6q and distal chromosome 1p, and no evidence for the genetic changes seen in post-pubertal tumors (Perlman et al., 1994 (Perlman et al., , 2000 Oosterhuis et al., 1988; Gibas et al., 1984) . Loss of heterozygosity and non-random deletion of chromosome 6q are frequently observed in many types of malignant tumors, although a tumor suppressor gene in this region has not been identi®ed (Cooke et al., 1996; Saito et al., 1992; Theile et al., 1996; Fujii et al., 1996; De Souza et al., 1995b; Cooney et al., 1996) . Similarly, deletion of 1p has been implicated in the pathogenesis of many tumors, and deletion of 1p has also been noted to be frequent in adolescent testicular GCT (Mathew et al., 1994; Castedo et al., 1989) . The most widely studied tumor showing 1p deletion is neuroblastoma, for which it portends a poor prognosis (Fong et al., 1989; Brodeur and Nakagawara, 1992) . The possibility that neuroblastomas and CESTs (both embryonal tumors exclusively involving very young children) may share a common cytogenetic deletion and a common tumor suppressor gene, merits examination. Cytogenetic data suggests that approximately 50% of CESTs show 1p deletion, and the common area of deletion involves the distal portion of 1p, with two cases showing a translocation involving a breakpoint at 1p36 (Perlman et al., 1994) . Several studies have utilized¯uorescence in situ hybridization using a 1p36 cosmid probe coupled with a chromosome centromeric probe. Such studies have reported that almost 80% of CEST have deletion of 1p36 (Perlman et al., 1996; Stock et al., 1994) . More recently, studies surveying genetic changes in CEST using comparative genomic hybridization (CGH) show a much lower frequency of 1p loss (Perlman et al., 2000) , although distal 1p is a region that is dicult to evaluate by CGH for technical reasons (du Manoir et al., 1995) . Interestingly, one of the most common alterations noted in CESTs by CGH was gain of 1q. This observation raises questions regarding the interpretation of the prior FISH studies. It is possible that the discrepant number of centromeric compared to 1p36 signals noted in these studies could re¯ect 1q gain rather than 1p loss.
In the present study, we analysed 18 CESTs for loss of heterozygosity using microsatellite loci in order to delineate the region of deletion on chromosome 6q and to verify the frequency of 1p deletion. All tumors showed pure endodermal sinus tumor histology. The clinical information is listed in Table 1 . Seventeen Oncogene (2001) 
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microsatellite markers previously mapped to 6q were used for this study. Based on genetic linkage maps (GeneMap99, Marsh®eld, Genethon) and human genome sequence database (http://www.ncbi.nlm.nih/ genome/human/), the order of these markers on chromosome 6q from centromere to telomere is D6S261, D6S262, D6S292, D6S311, D6S441, D6S1577, D6S255, D6S1633, D6S437, D6S415, IGF2R, D6S305, D6S264, D6S297, D6S446, D6S281.
For analysis of 1p36, two dinucleotide repeats were utilized (D1S1592, D1S548).
At least ®ve markers on 6q were polymorphic for each case. LOH of chromosome 6q was detected in 72% (13 of 18) of tumors. The minimal common region of deletion was de®ned by tumor 16, with the proximal and distal boundaries marked by D6S437 and D6S305. The distance between D6S437 and D6S305 is 4.3 ± 4.8 cM (Genethon and Marsh®ed linkage maps). The detailed results are summarized in Table 2 and representative cases illustrated in Figure 1 . Following the above studies, sucient DNA was available for analysis of 1p36 LOH in 13 normal/tumor pairs using two markers. Eleven tumors were informative with at least one marker, and ®ve of 11 showed loss of heterozygosity for one or both markers, and four of 11 showed loss at both markers (Table 2) .
Chromosome 6q may harbor multiple tumor suppressor genes, and has received much attention in recent years (Barghorn et al., 2001; Utada et al., 2000; Rodriguez et al., 2000; Srikantan et al., 1999) . Insulin growth factor receptor gene (IGF2R) has been proposed to be a candidate tumor suppressor gene, and it is located within the minimal common deleted Table 2 Loss of heterozygosity for markers on 6q and 1p
Five micron thick paran sections were H&E stained and used to guide the dissection of tumor and normal tissues in unstained sections. These were deparanized, hydrated, and digested with buer (10 mg/ml proteinase K, 50 mM Tris, 0.5% Tween, and 1 mM EDTA) at 558C overnight, followed by heat inactivation. The digests were used directly as template for PCR reaction with 1U Taq Gold Polymerase (Perkin Elmer Corporation, CT) 2 mM of each dATP, dGTP, dTTP, 0.025 mM of the dCTP and 0.05 mM of the 32 P-dCTP. All of the reactions were performed on a Perkin Elmer Cetus PCR system with denaturation at 958C for 10 min, followed by 35 cycles of denaturation at 948C for 30 s, annealing at 54 ± 638C (varied according to the pair of primers used) for 1 min and extension for 30 s. The PCR product was examined on a 6% polyacrylamide gel containing 7 M urea, 16TBE). &: Both alleles retained; N: not informative; D: Loss of one allele Figure 1 Loss of heterozygosity on 6q in representative tumors as indicated by multiple markers. For each marker, the tumor sample is on the right and the normal sample is on the left. LOH was de®ned as a reduction of the relative intensity of one of the allele by more than 50% in comparison with the normal DNA. All markers were con®rmed by repeat analysis region identi®ed in the present study. The function of IGF2R is to bind IGF2, a potent growth factor, and process it for degradation. Therefore, loss of IGF2R may result in increased IGF2 level. Loss of heterozygosity of IGF2R has been found in a high percentage of hepatocellular carcinomas and breast carcinomas (De Souza et al., 1995b; Hankins et al., 1996) . Mutation of the remaining copy has also been detected in those tumors (De Souza et al., 1995a; Hankins et al., 1996) . Furthermore, IGF2R is imprinted in all murine animals and in a minority of humans. Therefore, as an alternative to IGF2R mutation, it remains possible that the second allele has been inactivated via methylation.
This study also demonstrates a high frequency of deletion of distal 1p using markers to 1p36. The infrequent loss of larger regions of 1p, which would be detectable by CGH, suggests that this loss usually involves a small region of distal 1p. This supports the previous studies conducted using¯uorescence in situ hybridization that demonstrate a high frequency of 1p36 loss. Whether or not the tumor suppressor gene implicated is the same as that suggested for neuroblastoma awaits the identi®cation of this gene.
In summary, 72% of childhood endodermal sinus tumors possess loss of heterozygosity of chromosome 6q, with a minimal common region of deletion of 4.3 ± 4.8 cM¯anked by markers D6S437 and D6S305. The present study also con®rms that loss of 1p36 is commonly seen in childhood endodermal sinus tumors.
